MedPath

Validation Study of a Patch-based PSG System

Not Applicable
Conditions
Sleep Disorder
Interventions
Diagnostic Test: Polysomnography
Registration Number
NCT05310708
Lead Sponsor
Onera BV
Brief Summary

This study is a study that qualifies as "other clinical investigation" under Art. 82 MDR and §47 Abs. 3 MPDG with a CE-marked device that aims to demonstrate that the physiological signals from the Onera STS system are substantially equivalent to physiological systems recorded by traditional PSG systems. Furthermore, the study aims to identify the proportion of users who can successfully perform an overnight Onera STS study in an unsupervised home setting. The Onera STS will be used within its approved indication, and the study participants will not be subjected to additional invasive or burdensome procedures.

Detailed Description

Not available

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
300
Inclusion Criteria
  • 18 years and older
  • Either referral for a suspected sleep disorder requiring a sleep diagnostic study, or,
  • An already diagnosed sleep disorder requiring a planned follow-up PSG.
Exclusion Criteria
  • Inability to provide informed consent
  • History of allergic reactions to adhesives or hydrogels or a family history of adhesive skin allergies
  • Severe skin condition at sites of patch administration such as wounds, burns or on any damaged skin
  • Has an implanted cardiac stimulator or diaphragmatic pacer
  • Has an anatomical abnormality that, in the opinion of the Principal Investigator, makes the subject ineligible for inclusion
  • Will be exposed to high-frequency surgical equipment, near strong magnetic fields or with devices such as MRIs, external cardiac stimulators during their use of the Onera device

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Validation Study of a patch-based PSG systemPolysomnographyMeasuring and recording multiple physiological parameters from a patient which are used by clinicians to make a decision on the diagnosis of sleep.
Primary Outcome Measures
NameTimeMethod
EOG right1 year

Electrooculogram (EOG) is measured on the right side. Here, electrical activity of the eye is measured with an electrode and expressed in microvolt\[uV\].

EMG left1 year

Electromyogram (EMG) is measured on the left side. Here, electrical activity of the muscle is measured with an electrode and expressed in microvolt\[uV\].

EEG right1 year

Electroencephalogram (EEG) is measured on the right side. Here, electrical activity of the brain is measured with an electrode and expressed in microvolt\[uV\].

SpO21 year

Oxygen Saturation (SpO2) is derived from red and infrared Photoplethysmography (PPG) which is measured on the forehead with a reflective pulse oximetry sensor.

ECG1 year

Electrocardiogram (ECG) is measured on the chest. Here, electrical activity of the heart is measured with an electrode and expressed in microvolt\[mV\].

EMG right1 year

Electromyogram (EMG) is measured on the right side. Here, electrical activity of the muscle is measured with an electrode and expressed in microvolt\[uV\].

BioZ Flow1 year

Respiratory Flow (BioZ Flow) is derived from the bioimpedance which is measured on the chest with an electrode (expressed: \[a.u.\]).

EOG left1 year

Electrooculogram (EOG) is measured on the left side. Here, electrical activity of the eye is measured with an electrode and expressed in microvolt\[uV\].

EEG left1 year

Electroencephalogram (EEG) is measured on the left side. Here, electrical activity of the brain is measured with an electrode and expressed in microvolt\[uV\].

BioZ Effort1 year

Respiratory Effort (BioZ Effort) is derived from the bioimpedance which is measured on the chest with an electrode (expressed: \[a.u.\]).

Nasal Cannula Flow1 year

The Nasal Cannula Flow is measured on the belly using a cannula (expressed: \[mmH2O\]).

Body Position1 year

The body Position is derived from the accelerometer data of the x, y, and z axis, which is measured on the chest and expressed in degrees\[deg\].

Activity1 year

The activity is derived from the accelerometer data of the x, y, and z axis, which is measured on the chest and expressed in the gravitational force equivalent\[g\].

Snoring1 year

Snoring is measured with the microphone imbedded in the sensor on the chest and expressed in Decibel\[dB\].

EMG Leg1 year

Electromyogram (EMG) is measured on the lower leg. Here, electrical activity of the muscle is measured with an electrode and expressed in microvolt\[mV\].

Secondary Outcome Measures
NameTimeMethod
Wake Time1 year

The total time spend awake expressed in minutes or hours.

Time in REM1 year

The total time spend in the Rapid Eye Movement (REM) sleep stage, expressed in minutes or hours.

Total Sleep Time1 year

The total time spend asleep expressed in minutes or hours.

Time In Bed1 year

The total time spend in bed expressed in minutes or hours.

SOL1 year

Sleep Onset Latency (SOL) is the length of time that it takes to accomplish the transition from full wakefulness to sleep, expressed in minutes or hours.

REM Onset Latency1 year

The elapsed time between sleep onset and the onset of the first Rapid Eye Movement (REM) sleep period, expressed in minutes or hours.

WASO1 year

Wake After Sleep Onset (WASO) measures wakefulness, excluding the wakefulness occurring before sleep onset, and is expressed in minutes or hours.

ODI1 year

The Oxygen Desaturation Index (ODI) is the amount of times per hour of sleep that your blood oxygen level drops by 3% from baseline. The lower this amount the better the outcome.

Time in N11 year

The total time spend in the N1 sleep stage, expressed in minutes or hours.

REM1 year

Amount of time spend in the Rapid Eye Movement (REM) sleep stage, expressed in percentage \[%\].

AI1 year

The Arousal Index (AI) divides the total number of arousals by the number of hours of sleep, and therefore is an index for the sleep quality. The lower this amount, the better the outcome.

Time in N21 year

The total time spend in the N2 sleep stage, expressed in minutes or hours.

Time in NREM1 year

The total time spend in the Non Rapid Eye Movement (NREM), which contains of the N1, N2, N3 sleep stages, expressed in minutes or hours.

SpO21 year

Oxygen Saturation (SpO2) is derived from red and infrared Photoplethysmography (PPG) which is measured on the forehead with a reflective pulse oximetry sensor. This will be expressed in the mean, the minimum, and the maximum.

Time in N31 year

The total time spend in the N3 sleep stage, expressed in minutes or hours.

NREM1 year

Amount of time spend in the Non Rapid Eye Movement (NREM) sleep stage, expressed in percentage \[%\].

AHI1 year

The Apnea Hypopnea Index (AHI) is the total amount of apnea or hypopnea event per hour of sleep, and therefore is an index for the severity of sleep apnea. The lower this amount, the better the outcome.

HR1 year

Heart Rate (HR) is the number of times the heart beats per minute, is derived from the Electrocardiogram (ECG), and expressed in beats per minute\[bpm\].

Set-up Time PSG (not applicable for application in unsupervised home setting)1 year

Comparison of the setup time (fitting and activation) between the Onera STS system and a traditional Polysomnography (PSG) system.

Trial Locations

Locations (7)

Schlaf- u. Beatmungszentrum Ulm/Blaubeuren

🇩🇪

Blaubeuren, Germany

American Sleep Clinic

🇩🇪

Frankfurt, Frankfurt Am Main, Germany

Ruhrlandklinik, Zentrum für Schlaf- und Telemedizin

🇩🇪

Essen, Germany

VAMED Klinik Hagen-Ambrock

🇩🇪

Hagen, Germany

Evang. Kliniken Essen-Mitte

🇩🇪

Essen, Germany

Universitätsklinikum Giessen und Marburg

🇩🇪

Marburg, Germany

Krankenhaus Bethanien

🇩🇪

Solingen, Germany

© Copyright 2025. All Rights Reserved by MedPath